| RESOLUTION CHEMICALS LIMITED Patent applications |
| Patent application number | Title | Published |
|---|
| 20110171300 | DELTA 9 TETRAHYDROCANNABINOL DERIVATIVES - A compound of formula (I) | 07-14-2011 |
| 20110011959 | Particle Size Reduction Apparatus, and Use Thereof - A sterilisable particle-size reduction apparatus, component parts thereof and a method of sterilising and validating sterility thereof are provided. Also provided is use thereof to prepare sterile suspensions of drugs. | 01-20-2011 |
| 20100197646 | SOLVENT-BASED STERILISATION OF PHARMACEUTICALS - A sterile composition of a pharmaceutical compound is prepared by combining solvent with a non-sterile pharmaceutical compound to form a solution and filtering to yield a sterile pharmaceutical compound, optionally removing all or part of the solvent, and under sterile conditions combining the compound with a pharmaceutically acceptable carrier. | 08-05-2010 |
| 20100099653 | Particle Size Reduction Apparatus, and Use Thereof - A sterilisable particle-size reduction apparatus, component parts thereof and a method of sterilising and validating sterility thereof are provided. Also provided is use thereof to prepare sterile suspensions of drugs. | 04-22-2010 |
| 20100087518 | DELTA 9 - TETRAHYDROCANNABINOL PROCESSING - The present invention provides a process for handling Δ9-THC, which comprises preparing a solution of Δ9-THC in a solvent which exists as a gas at room temperature and atmospheric pressure. The invention also provides solutions of Δ9-THC in the solvent and solid preparations of Δ9-THC. | 04-08-2010 |
| 20100012114 | PARTICLE-SIZE REDUCTION APPARATUS, AND USE THEREOF - A sterilisable particle-size reduction apparatus, component parts thereof and a method of sterilising and validating sterility thereof are provided. Also provided is use thereof to prepare sterile suspensions of drugs. | 01-21-2010 |
| 20090253783 | Production of Delta 9 Tetrahydrocannabinol - The present invention provides isolated, purified Δ9 THC. In another embodiment, the invention provides pharmaceutical compositions comprising isolated, purified Δ9 THC and a pharmaceutically acceptable carrier. In another embodiment, the invention provides methods of preparing pharmaceutical compositions comprising isolated, purified Δ9 THC and a pharmaceutically acceptable carrier. | 10-08-2009 |
